Pages that link to "Q48197949"

The following pages link to Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study (Q48197949):

Displaying 23 items.

• Memantine inhibits α3β2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteries (Q21134148) (← links)
• Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses (Q24619395) (← links)
• The chemical biology of clinically tolerated NMDA receptor antagonists (Q28248958) (← links)
• Pharmacodynamics of memantine: an update (Q30490604) (← links)
• Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data (Q30580986) (← links)
• NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia (Q33565598) (← links)
• Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease (Q34038310) (← links)
• The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease (Q34268122) (← links)
• A new strategy for antidepressant prescription (Q34371007) (← links)
• Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin (Q35013054) (← links)
• Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected]. (Q35087517) (← links)
• Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD (Q36088786) (← links)
• Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine (Q38773140) (← links)
• Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones (Q42044413) (← links)
• Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour (Q42614188) (← links)
• Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats (Q43698577) (← links)
• Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action (Q48491954) (← links)
• Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists. (Q52006941) (← links)
• Activation of Brain Histaminergic Neurotransmission: A Mechanism for Cognitive Effects of Memantine in Alzheimer's Disease (Q54402879) (← links)
• Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc (Q60919920) (← links)
• MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats (Q73755286) (← links)
• Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice (Q78228737) (← links)
• Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc<sup/> (Q95818846) (← links)